Avalo Therapeutics, Inc. — Director's Dealing 2021

Jul 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerecor Inc. (CERC)
CIK: 0001534120
Period of Report: 2021-06-30

Reporting Person: Gutry Phil (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-30	Stock Option (Right to Buy)	$3.27	A	3142	Acquired	2031-06-30	Common Stock (3142)	Direct

Footnotes

F1: 100% of this stock option will immediately vest on the date that it is granted.